MKI67 and colonic neoplasm: The expression of Ki67 were markedly decreased in linagliptin treated groups compared with control group (Figures 4D, E), indicating that linagliptin effectively inhibited proliferation of HCT116 cells in human colon tumor-bearing xenografted mice.